Metabolic syndrome diminishes insulin-induced Akt activation and causes a redistribution of Akt-interacting proteins in cardiomyocytes
- PMID: 31995605
- PMCID: PMC6988918
- DOI: 10.1371/journal.pone.0228115
Metabolic syndrome diminishes insulin-induced Akt activation and causes a redistribution of Akt-interacting proteins in cardiomyocytes
Abstract
Metabolic syndrome (MetS) is a cluster of cardiometabolic risk factors, with insulin resistance as a critical component for its development. Insulin signaling in the heart leads to Akt (also known as PKB) activation, a serine/threonine protein kinase, which regulates cardiac glucose metabolism and growth. Cardiac metabolic inflexibility, characterized by impaired insulin-induced glucose uptake and oxidation, has been reported as an early and consistent change in the heart of different models of MetS and diabetes; however, the evaluation of Akt activation has yielded variable results. Here we report in cardiomyocytes of MetS rats, diminished insulin-induced glucose uptake and Akt activation, evaluated by its impaired mobilization towards the plasma membrane and phosphorylation, and reflected in a re-distribution of its interacting proteins, assessed by label-free mass spectrometry (data are available via ProteomeXchange with identifier PXD013260). We report 45 proteins with diminished abundance in Akt complex of MetS cardiomyocytes, mainly represented by energy metabolism-related proteins, and also, 31 Akt-interacting proteins with increased abundance, which were mainly related to contraction, endoplasmic reticulum stress, and Akt negative regulation. These results emphasize the relevance of Akt in the regulation of energy metabolism in the heart and highlight Akt-interacting proteins that could be involved in the detrimental effects of MetS in the heart.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Titin and CK2α are New Intracellular Targets in Acute Insulin Application-Associated Benefits on Electrophysiological Parameters of Left Ventricular Cardiomyocytes From Insulin-Resistant Metabolic Syndrome Rats.Cardiovasc Drugs Ther. 2020 Aug;34(4):487-501. doi: 10.1007/s10557-020-06974-2. Cardiovasc Drugs Ther. 2020. PMID: 32377826
-
Neuregulin-1β promotes glucose uptake via PI3K/Akt in neonatal rat cardiomyocytes.Am J Physiol Endocrinol Metab. 2016 May 1;310(9):E782-94. doi: 10.1152/ajpendo.00259.2015. Epub 2016 Mar 15. Am J Physiol Endocrinol Metab. 2016. PMID: 26979522
-
Impaired stimulation of glucose transport in cardiac myocytes exposed to very low-density lipoproteins.Nutr Metab Cardiovasc Dis. 2016 Jul;26(7):614-622. doi: 10.1016/j.numecd.2016.01.010. Epub 2016 Feb 3. Nutr Metab Cardiovasc Dis. 2016. PMID: 27052924
-
Protein kinase B in the diabetic heart.Mol Cell Biochem. 2003 Jul;249(1-2):31-8. Mol Cell Biochem. 2003. PMID: 12956395 Review.
-
The insulin receptor family in the heart: new light on old insights.Biosci Rep. 2022 Jul 29;42(7):BSR20221212. doi: 10.1042/BSR20221212. Biosci Rep. 2022. PMID: 35766350 Free PMC article. Review.
Cited by
-
Transplantation of committed pre-adipocytes from brown adipose tissue improves whole-body glucose homeostasis.iScience. 2024 Jan 17;27(2):108927. doi: 10.1016/j.isci.2024.108927. eCollection 2024 Feb 16. iScience. 2024. PMID: 38327776 Free PMC article.
-
Cardiac Insulin Resistance in Subjects With Metabolic Syndrome Traits and Early Subclinical Atherosclerosis.Diabetes Care. 2023 Nov 1;46(11):2050-2057. doi: 10.2337/dc23-0871. Diabetes Care. 2023. PMID: 37713581 Free PMC article.
-
Nitrative Modification of Caveolin-3: A Novel Mechanism of Cardiac Insulin Resistance and a Potential Therapeutic Target Against Ischemic Heart Failure in Prediabetic Animals.Circulation. 2023 Apr 11;147(15):1162-1179. doi: 10.1161/CIRCULATIONAHA.122.063073. Epub 2023 Mar 8. Circulation. 2023. PMID: 36883479
-
Metabolic Syndrome Is Associated With Impaired Insulin-Stimulated Myocardial Glucose Metabolic Rate in Individuals With Type 2 Diabetes: A Cardiac Dynamic 18F-FDG-PET Study.Front Cardiovasc Med. 2022 Jun 29;9:924787. doi: 10.3389/fcvm.2022.924787. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35845046 Free PMC article.
-
Potential roles of Garcinia family as antimetabolic syndrome.J Adv Pharm Technol Res. 2022 Jan-Mar;13(1):1-6. doi: 10.4103/japtr.japtr_218_21. Epub 2022 Jan 21. J Adv Pharm Technol Res. 2022. PMID: 35223433 Free PMC article. Review.
References
-
- Grundy SM, Hansen B, Smith SC Jr., Cleeman JI, Kahn RA. Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Arterioscler Thromb Vasc Biol. 2004;24(2):e19–24. Epub 2004/02/10. 10.1161/01.ATV.0000112379.88385.67 . - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous
